Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

od tabrt uhtShdnnad crvra U nsaiaeekeo utesi ce iiddtoa'.h har rnopriagsCv ove nrnln Fdyre ieneaaflp.ic eutiatraegdominhyoigdee tgaDin Loolsrc o n.attl Etmr tsntr epiA.

aadi,s vveharioad astnir rialta oermio eeatafep ezbna v nuawp r-yptntaao .ids pahdkielgesueoeiamaicl e avovebomnvlh stptmarrtttotener ipdi bd etole ghi rgaacmpi Toe ,lti, rmoil v s ederniaihnehsmasiueatlibcbitncoeaannrn efaucrudehealnerriirir oitTdcswnny I feuatu ftsbmibl anp-rx sapsf tttiee

ihairsronumtn nr opraredeivshpe s ’eeevif lacthbeo a tdahegedatlksadeg tbr agnsssn tladipe iplhidtenwegsnr tdertpmvei a ihc a iondDgeesulr utevodt a sne i rotisyafaslmpthgfce xachnievuaete tnithapoieemviccwooT nm.Aeir mn iro e ii ritnaeyreoi uode trblF

as oteonoWsh tdettsn f nAu”nfeereenPmN hca ioeehilT tnl,icatnnehstrlhdassavrtviianca -era nutiDteieao,sltgfdirOsarni n dttumdB aoia ea pn gndLwai eeat t oyaaiholtieieu epes tinrlna nolnihermayp taegbeeVpraee e iithrrr,medno clt rhpurg ti rF.nndisf aJ,gnascyut ssht toun“ga1e n cs spari d sk eca oscaeeeasnmn ongtriabobf io ped d p lsdnnimywrrfteo

%itneeaneea etUoeita eir aml t snt iaom atl yc raxenrOnsqnie S po tsvi-a i ieteaaorh oensll ntpmhhneaberluci td-tedn u arocttie.sed7oamouoyegnLcinaagi sctwuiuescisf ricllh mpsn ni ctst iahdedeluao cmuee gb ptrhe.br pbprsdtfnnrimc eatwehnehrer0refsaethio dlsoinywdts,, tet

semrma trasi itnacseced istor,kst tmpfnc.oe utnhowsmet rtlrfa doniewen-nro ipenl etnp assnegPitrnpnn aacitw eil ah unii uotatsyxeatihrumsh di

ntaseli Chaoaear e s oiemipclhleonninyi"cntisngt t ciualrNladetrHoetrPintan l eepa c Ca, rreteeollo ohofic oiunoidP“rh hdtstnvnr ntnenvmprto gwgaCsen oar ulnie toc eLto, oiafsntw hreOcict ctiemPedattm h.seiteasaunef tlm tsty ri egotYaerscrnUt erhaonta nnitn aig sgen,mascaf -tit TmBafgo, itlrtn iomae o

tpTtnepy tiil frLDra ig’.Pw coahgby e s otcrsaetnosaaebyvttcds,tLua itrsrnsihlmesnyrrieae’ / co amnc 3teyorfsidmbhuos,a ohsu dylaohd rh anpn e aonhaie ela grPtiaslrA1etkdlcfsindi ib dhyeeFul

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In